1050392-08-9

Upstream product

• 191655-29-5 (S)-(3-benzyloxy-2-t-butoxycarbonylaminopropoxy)acetic acid t-butyl ester 
• 138526-69-9 3,4,5-trifluoro-1-bromobenzene 
• 156006-28-9 3,4,5-trifluorophenylmagnesium bromide 
• 937816-19-8 (3S,5R)-3-hydroxymethyl-5-(3,4,5-trifluorophenyl)morpholin-4-carboxylic acid 9H-fluoren-9-yl methyl ester 
• 937400-30-1 {(S)-1-benzyloxymethyl-2-[2-oxo-2-(3,4,5-trifluorophenyl)ethoxy]ethyl}carbamic acid tert-butyl ester 
• 937400-29-8 (S)-3-benzyloxymethyl-5-oxomorpholine-4-carboxylic acid tert-butyl ester 
• 937400-31-2 [(3S,5R)-5-(3,4,5-trifluorophenyl)morpholine-3-yl]methanol 
• 937400-28-7 (5S)-5-[(benzyloxy)methyl]morpholin-3-one 
• 79-37-8 oxalyl dichloride 
• 1050392-05-6 1-[(3R,5R)-5-(3,4,5-trifluorophenyl)morpholin-3-yl]ethanol 

Downstream Products

• 1004791-19-8 (Z)-(1S,6R,9aR)-3-[3-methoxy-4-(4-methyl-1H-imidazole-1-yl)benzylidene]-1-methyl-6-(3,4,5-trifluorophenyl)tetrahydro[1,4]oxazino[3,4-c][1,4]oxazine-4-one 
• 1050392-12-5 (Z)-(1R,6R,9aR)-3-[3-methoxy-4-(4-methylimidazol-1-yl)benzylidene]-1-methyl-6-(3,4,5-trifluorophenyl)tetrahydro-[1,4]oxazino[3,4-c][1,4]oxazin-4-one 

Relevant academic research and scientific papers

TWO CYCLIC OXOMORPHORIN DERIVATIVES

The present invention relates to a compound represented by formula (I): wherein R1 represents a C1-3 alkyl group, R2 represents a hydrogen atom or a C1-3 alkyl group, Ar represents a phenyl group or the like which may be substituted with 1 to 3 substituents, X represents an oxygen atom or the like, n and m are the same or different and integers of 0 to 2, or a pharmacologically acceptable salt, and use thereof as a medicament.